Who
Prakash Raman
Director
Company insider
Files Form 4 as: Director, Black Diamond Therapeutics; Director, Olema Pharmaceuticals.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Apr 2024
- Last trade
- 18 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 21 Sep 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K6,801 at $1.93 | filing |
| 18 Sep 2026filed 21 Sep 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K6,801 at $1.93 | filing |
| 26 Jun 2026filed 29 Jun 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 Jun 2026filed 29 Jun 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 19 Jun 2026filed 22 Jun 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K7,907 at $1.66 | filing |
| 19 Jun 2026filed 22 Jun 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K7,907 at $1.66 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,911 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,150 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,911 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,150 at $0.00 | filing |
| 20 Mar 2026filed 20 Mar 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K6,105 at $2.15 | filing |
| 20 Mar 2026filed 20 Mar 2026 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K6,105 at $2.15 | filing |
| 12 Dec 2025filed 15 Dec 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K4,665 at $2.76 | filing |
| 19 Sep 2025filed 22 Sep 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K3,843 at $3.35 | filing |
| 20 Jun 2025filed 20 Jun 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K5,526 at $2.33 | filing |
| 12 Jun 2025filed 12 Jun 2025 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,550 at $0.00 | filing |
| 21 Mar 2025filed 21 Mar 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K6,848 at $1.88 | filing |
| 13 Dec 2024filed 16 Dec 2024 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K5,150 at $2.50 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.